Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma

Dunfa Peng, Tianling Hu, Mohammed Soutto, Abbes Belkhiri, Alexander Zaika, Wael El-Rifai

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective: To investigate the potential tumour suppressor functions of glutathione peroxidase 7 (GPX7) and examine the interplay between epigenetic and genetic events in regulating its expression in oesophageal adenocarcinomas (OAC). Design: In vitro and in vivo cell models were developed to investigate the biological and molecular functions of GPX7 in OAC. Results: Reconstitution of GPX7 in OAC cell lines, OE33 and FLO-1, significantly suppressed growth as shown by the growth curve, colony formation and EdU proliferation assays. Meanwhile, GPX7-expressing cells displayed significant impairment in G1/S progression and an increase in cell senescence. Concordant with the above functions, Western blot analysis displayed higher levels of p73, p27, p21 and p16 with a decrease in phosphorylated retinoblastoma protein (RB), indicating its increased tumour suppressor activities. On the contrary, knockdown of GPX7 in HET1A cells (an immortalised normal oesophageal cell line) rendered the cells growth advantage as indicated with a higher EdU rate, lower levels of p73, p27, p21 and p16 and an increase in phosphorylated RB. We confirmed the tumour suppressor function in vivo using GPX7-expressing OE33 cells in a mouse xenograft model. Pyrosequencing of the GPX7 promoter region (-162 to +138) demonstrated location-specific hypermethylation between +13 and +64 in OAC (69%, 54/78). This was significantly associated with the downregulation of GPX7 (p<0.01). Neither mutations in the coding exons of GPX7 nor DNA copy number losses were frequently present in the OAC examined (<5%). Conclusions: Our data suggest that GPX7 possesses tumour suppressor functions in OAC and is silenced by location-specific promoter DNA methylation.

Original languageEnglish (US)
Pages (from-to)540-551
Number of pages12
JournalGut
Volume63
Issue number4
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Glutathione Peroxidase
Methylation
Adenocarcinoma
Neoplasms
Retinoblastoma Protein
Growth
Cell Line
Cell Aging
DNA Methylation
Heterografts
Genetic Promoter Regions
Epigenomics
Exons
Down-Regulation
Western Blotting
Mutation
DNA

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma. / Peng, Dunfa; Hu, Tianling; Soutto, Mohammed; Belkhiri, Abbes; Zaika, Alexander; El-Rifai, Wael.

In: Gut, Vol. 63, No. 4, 01.01.2014, p. 540-551.

Research output: Contribution to journalArticle

@article{c3f70781b3f04361a132e29f311d3e54,
title = "Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma",
abstract = "Objective: To investigate the potential tumour suppressor functions of glutathione peroxidase 7 (GPX7) and examine the interplay between epigenetic and genetic events in regulating its expression in oesophageal adenocarcinomas (OAC). Design: In vitro and in vivo cell models were developed to investigate the biological and molecular functions of GPX7 in OAC. Results: Reconstitution of GPX7 in OAC cell lines, OE33 and FLO-1, significantly suppressed growth as shown by the growth curve, colony formation and EdU proliferation assays. Meanwhile, GPX7-expressing cells displayed significant impairment in G1/S progression and an increase in cell senescence. Concordant with the above functions, Western blot analysis displayed higher levels of p73, p27, p21 and p16 with a decrease in phosphorylated retinoblastoma protein (RB), indicating its increased tumour suppressor activities. On the contrary, knockdown of GPX7 in HET1A cells (an immortalised normal oesophageal cell line) rendered the cells growth advantage as indicated with a higher EdU rate, lower levels of p73, p27, p21 and p16 and an increase in phosphorylated RB. We confirmed the tumour suppressor function in vivo using GPX7-expressing OE33 cells in a mouse xenograft model. Pyrosequencing of the GPX7 promoter region (-162 to +138) demonstrated location-specific hypermethylation between +13 and +64 in OAC (69{\%}, 54/78). This was significantly associated with the downregulation of GPX7 (p<0.01). Neither mutations in the coding exons of GPX7 nor DNA copy number losses were frequently present in the OAC examined (<5{\%}). Conclusions: Our data suggest that GPX7 possesses tumour suppressor functions in OAC and is silenced by location-specific promoter DNA methylation.",
author = "Dunfa Peng and Tianling Hu and Mohammed Soutto and Abbes Belkhiri and Alexander Zaika and Wael El-Rifai",
year = "2014",
month = "1",
day = "1",
doi = "10.1136/gutjnl-2013-304612",
language = "English (US)",
volume = "63",
pages = "540--551",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma

AU - Peng, Dunfa

AU - Hu, Tianling

AU - Soutto, Mohammed

AU - Belkhiri, Abbes

AU - Zaika, Alexander

AU - El-Rifai, Wael

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: To investigate the potential tumour suppressor functions of glutathione peroxidase 7 (GPX7) and examine the interplay between epigenetic and genetic events in regulating its expression in oesophageal adenocarcinomas (OAC). Design: In vitro and in vivo cell models were developed to investigate the biological and molecular functions of GPX7 in OAC. Results: Reconstitution of GPX7 in OAC cell lines, OE33 and FLO-1, significantly suppressed growth as shown by the growth curve, colony formation and EdU proliferation assays. Meanwhile, GPX7-expressing cells displayed significant impairment in G1/S progression and an increase in cell senescence. Concordant with the above functions, Western blot analysis displayed higher levels of p73, p27, p21 and p16 with a decrease in phosphorylated retinoblastoma protein (RB), indicating its increased tumour suppressor activities. On the contrary, knockdown of GPX7 in HET1A cells (an immortalised normal oesophageal cell line) rendered the cells growth advantage as indicated with a higher EdU rate, lower levels of p73, p27, p21 and p16 and an increase in phosphorylated RB. We confirmed the tumour suppressor function in vivo using GPX7-expressing OE33 cells in a mouse xenograft model. Pyrosequencing of the GPX7 promoter region (-162 to +138) demonstrated location-specific hypermethylation between +13 and +64 in OAC (69%, 54/78). This was significantly associated with the downregulation of GPX7 (p<0.01). Neither mutations in the coding exons of GPX7 nor DNA copy number losses were frequently present in the OAC examined (<5%). Conclusions: Our data suggest that GPX7 possesses tumour suppressor functions in OAC and is silenced by location-specific promoter DNA methylation.

AB - Objective: To investigate the potential tumour suppressor functions of glutathione peroxidase 7 (GPX7) and examine the interplay between epigenetic and genetic events in regulating its expression in oesophageal adenocarcinomas (OAC). Design: In vitro and in vivo cell models were developed to investigate the biological and molecular functions of GPX7 in OAC. Results: Reconstitution of GPX7 in OAC cell lines, OE33 and FLO-1, significantly suppressed growth as shown by the growth curve, colony formation and EdU proliferation assays. Meanwhile, GPX7-expressing cells displayed significant impairment in G1/S progression and an increase in cell senescence. Concordant with the above functions, Western blot analysis displayed higher levels of p73, p27, p21 and p16 with a decrease in phosphorylated retinoblastoma protein (RB), indicating its increased tumour suppressor activities. On the contrary, knockdown of GPX7 in HET1A cells (an immortalised normal oesophageal cell line) rendered the cells growth advantage as indicated with a higher EdU rate, lower levels of p73, p27, p21 and p16 and an increase in phosphorylated RB. We confirmed the tumour suppressor function in vivo using GPX7-expressing OE33 cells in a mouse xenograft model. Pyrosequencing of the GPX7 promoter region (-162 to +138) demonstrated location-specific hypermethylation between +13 and +64 in OAC (69%, 54/78). This was significantly associated with the downregulation of GPX7 (p<0.01). Neither mutations in the coding exons of GPX7 nor DNA copy number losses were frequently present in the OAC examined (<5%). Conclusions: Our data suggest that GPX7 possesses tumour suppressor functions in OAC and is silenced by location-specific promoter DNA methylation.

UR - http://www.scopus.com/inward/record.url?scp=84895466271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895466271&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2013-304612

DO - 10.1136/gutjnl-2013-304612

M3 - Article

C2 - 23580780

AN - SCOPUS:84895466271

VL - 63

SP - 540

EP - 551

JO - Gut

JF - Gut

SN - 0017-5749

IS - 4

ER -